This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of British Columbia directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
The Risk of Cardiovascular Events in Individuals With Primary Glomerular Diseases.
American journal of kidney diseases : the official journal of the National Kidney Foundation · 2022 · first author
Perceptions of Multidisciplinary Renal Team Members toward Home Dialysis Therapies.
Kidney360 · 2021 · senior author
Temporal Trends in Hemoglobin, Use of Erythropoiesis Stimulating Agents, and Major Clinical Outcomes in Incident Dialysis Patients in Canada.
Kidney international reports · 2021 · first author
Latest funding
- $15,000
Establishing Research Priorities and a Platform for Knowledge Generation and Mobilization for the Integrated Care of People with Chronic Kidney Disease: The Canadian CKD Clinic Network
CIHR · 2024 · Co-investigator
- $520,200
Glucocorticoids or Avacopan in peopLe with high-risk renal Anti-Neutrophil cytoplasm antibody associated vasculitis Trial (GALANT) - Pilot
CIHR · 2023 · Co-investigator
- $236,385
Improving cardiovascular risk prediction in patients with glomerular disease
CIHR · 2021 · Principal investigator
13 publications.
The Risk of Cardiovascular Events in Individuals With Primary Glomerular Diseases.
Canney M, Gunning HM, Zheng Y, Rose C, Jauhal A, Hur SA, Sahota A, Reich HN, Barbour SJ
Perceptions of Multidisciplinary Renal Team Members toward Home Dialysis Therapies.
Poinen K, Van Der Hoek M, Copland MA, Tennankore K, Canney M
Temporal Trends in Hemoglobin, Use of Erythropoiesis Stimulating Agents, and Major Clinical Outcomes in Incident Dialysis Patients in Canada.
Canney M, Birks P, Shao S, Parfrey P, Djurdjev O, Levin A
Maintaining the Uptake of Peritoneal Dialysis During the COVID-19 Pandemic: A Research Letter.
Canney M, Er L, Antonsen J, Copland M, Singh RS, Levin A
Quantifying Missed Opportunities for Recruitment to Home Dialysis Therapies.
Poinen K, Er L, Copland MA, Singh RS, Canney M
Quantifying Duration of Proteinuria Remission and Association with Clinical Outcome in IgA Nephropathy.
Canney M, Barbour SJ, Zheng Y, Coppo R, Zhang H, Liu ZH, Matsuzaki K, Suzuki Y, Katafuchi R, Reich HN, Cattran D, International IgA Nephropathy Network, International IgA Nephropathy Network Investigators
COVID-19 Status, Symptom Burden, and Characteristics of Dialysis Patients Residing in Areas of Community Transmission: Research Letter.
Gale J, Clark DA, Bohm C, Canney M, Davis I, LeBlanc JJ, Shorter AM, Suri RS, Vinson AJ, West KA, Tennankore KK
Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool.
Barbour SJ, Canney M, Coppo R, Zhang H, Liu ZH, Suzuki Y, Matsuzaki K, Katafuchi R, Induruwage D, Er L, Reich HN, Feehally J, Barratt J, Cattran DC, International IgA Nephropathy Network
A Provincial Survey of the Contemporary Management of Autosomal Dominant Polycystic Kidney Disease.
Yi TW, Levin A, Bevilacqua M, Canney M
Socioeconomic Position and Incidence of Glomerular Diseases.
Canney M, Induruwage D, Sahota A, McCrory C, Hladunewich MA, Gill J, Barbour SJ
Establishing Research Priorities and a Platform for Knowledge Generation and Mobilization for the Integrated Care of People with Chronic Kidney Disease: The Canadian CKD Clinic Network
Principal investigators: Levin, Adeera
Keywords: Chronic Kidney Disease; Integrated Knowledge Mobilization; Research Prioritization
Glucocorticoids or Avacopan in peopLe with high-risk renal Anti-Neutrophil cytoplasm antibody associated vasculitis Trial (GALANT) - Pilot
Principal investigators: Walsh, Michael W; Massicotte-Azarniouch, David; Mendel, Arielle
Keywords: Anca; Autoimmune Disease; Dialysis; Kidney Failure; Kidney Function; Vasculitis
Improving cardiovascular risk prediction in patients with glomerular disease
Principal investigators: Barbour, Sean; Canney, Mark; Fordyce, Christopher B
Keywords: Cardiovascular Disease; Focal Segmental Glomerulosclerosis; Framingham Risk Score; Glomerulonephritis; Iga Nephropathy; Membranous Nephropathy; Minimal Change Disease; Prediction Models
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Karthik Tennankore and Clara Bohm: 10 shared papers
- Adeera Levin and Mark Canney: 5 shared papers
- Daniel Cattran and Adeera Levin: 3 shared papers
- Adeera Levin and Clara Bohm: 3 shared papers
- Jagbir Gill and Adeera Levin: 2 shared papers
- Adeera Levin and Karthik Tennankore: 2 shared papers
- Jagbir Gill and Karthik Tennankore: 1 shared paper
- Jagbir Gill and Mark Canney: 1 shared paper
- Daniel Cattran and Mark Canney: 1 shared paper
- Adeera Levin and Patrick Parfrey: 1 shared paper
- Karthik Tennankore and Patrick Parfrey: 1 shared paper
- Karthik Tennankore and Mark Canney: 1 shared paper
- Clara Bohm and Mark Canney: 1 shared paper
- Patrick Parfrey and Mark Canney: 1 shared paper
- Internal Medicine
- Medicine/Nephrology
- Nephrology
- Medicine
- Other
Co-authors at University of British Columbia, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Adeera Levin
Nephrology
5 shared papers, latest 2021
Jagbir Gill
Medicine/Nephrology
1 shared papers, latest 2020
Daniel Cattran
Medicine/Nephrology
1 shared papers, latest 2021
Karthik Tennankore
Internal Medicine
1 shared papers, latest 2021
Clara Bohm
Internal Medicine
1 shared papers, latest 2020
Patrick Parfrey
Medicine
1 shared papers, latest 2021
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.